Molecular phenotypes of DCIS predict overall and invasive recurrence.
dc.contributor.author | Williams, C | |
dc.contributor.author | Barnes, N | |
dc.contributor.author | Cramer, Angela | |
dc.contributor.author | Johnson, R | |
dc.contributor.author | Cheema, K | |
dc.contributor.author | Morris, J | |
dc.contributor.author | Howe, M | |
dc.contributor.author | Bundred, N | |
dc.date.accessioned | 2015-03-27T15:11:37Z | en |
dc.date.available | 2015-03-27T15:11:37Z | en |
dc.date.issued | 2015-02-12 | en |
dc.identifier.citation | Molecular phenotypes of DCIS predict overall and invasive recurrence. 2015: Ann Oncol | en |
dc.identifier.issn | 1569-8041 | en |
dc.identifier.pmid | 25678586 | en |
dc.identifier.doi | 10.1093/annonc/mdv062 | en |
dc.identifier.uri | http://hdl.handle.net/10541/347198 | en |
dc.description.abstract | Molecular phenotypes of invasive breast cancer predict early recurrence. DCIS exhibits similar phenotypes but their frequency and significance remain unclear. To determine whether DCIS molecular phenotypes predict recurrence, 314 women (median age 57.7 years) with primary DCIS who were screened or entered DCIS trials in a specialist breast unit from 1990-2010 were studied. | |
dc.language | ENG | en |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Annals of oncology : official journal of the European Society for Medical Oncology / ESMO | en |
dc.title | Molecular phenotypes of DCIS predict overall and invasive recurrence. | en |
dc.type | Article | en |
dc.contributor.department | Department of Academic Surgery, University Hospital of South Manchester, Manchester, United Kingdom | en |
dc.identifier.journal | Annals of Oncology | en |
html.description.abstract | Molecular phenotypes of invasive breast cancer predict early recurrence. DCIS exhibits similar phenotypes but their frequency and significance remain unclear. To determine whether DCIS molecular phenotypes predict recurrence, 314 women (median age 57.7 years) with primary DCIS who were screened or entered DCIS trials in a specialist breast unit from 1990-2010 were studied. |